Here At Last: A New Era For Clinical Trials In The EU
Executive Summary
A long-awaited regulation introduces major changes in the way that clinical trials are conducted across the EU, including a single application portal and new trial transparency requirements.
You may also be interested in...
EU Clinical Trials System Should Be Free Of Major Bugs Within Three Months
A senior executive at the European Medicines Agency says that all major technical problems with the EU Clinical Trials Information System are close to being resolved, and will free up time to focus on delivering much needed improvements and new functionalities.
Pharma Industry Urges UK To Make Good On Its Clinical Trial Promises
Research-based drug companies are asking for swift implementation of UK clinical trial reforms to ensure the country does not lose out on commercial trial activity amid challenges such as capacity constraints in the NHS and delays in regulatory approvals.
Straightforward But Technical: Transferring Existing Studies To EU Clinical Trial Portal
At a webinar organized by the European Medicines Agency, EU member states discussed their experiences with reviewing the requests made by trial sponsors to switch existing studies to the Clinical Trial Regulation.